Protective effects of Terminalia arjuna bark extracts against glycation induced protein damage, oxidative stress, and hyperpigmentation
Open Access
- 11 June 2024
- journal article
- Published by Sri Lanka Journals Online in Ceylon Journal of Science
- Vol. 53 (3) , 389-397
Abstract
Glycation induced protein damage, and oxidative stress play a critical role in the development of chronic diabetic complications and skin aging. Terminalia arjuna (Kumbuk) bark has been used for medicinal purposes for thousands of years. Main objectives of the study were to assess in vitro inhibitory effects of T. arjuna bark extracts on glycation induced protein cross-linking and to assess heat stability of those effects. Additional objectives were to assess antityrosinase effects, total antioxidant activity, phenolic content, and flavonoid content of T. arjuna extracts. The effects of T. arjuna bark extracts were assessed using electrophoresis-based and colorimetric methods. Experiments were repeated on three separate occasions with appropriate controls. Fiji/ImageJ software was used to quantify the extent of protein cross-linking. Statistical significance of the differences of colorimetric assays was calculated using ANOVA. P<0.05 was considered statistically significant. T. arjuna extracts showed strong inhibitory effects on glycation induced protein cross-linking and on tyrosinase activity. These effects showed heat stability to a great extent. Methanol extract demonstrated higher inhibitory effects on protein cross-linking compared to that of ethanol extracts. T. arjuna extracts demonstrated high total antioxidant capacity, total phenolic and flavonoid content. Furthermore, antioxidant capacity showed a significantly positive correlation with polyphenolic and flavonoid contents. The results provide evidence to suggest the beneficial effects of T. arjuna bark in alleviating some mechanisms that cause chronic diabetic complications and skin aging. Findings also provide in vitro evidence to validate the traditional use of T. arjuna bark in diabetes mellitus and skin disorders.Keywords
Funding Information
- University of Peradeniya (RG/2018/32/M)
This publication has 32 references indexed in Scilit:
- Advanced Glycation End Products, Bone Health, and Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes, 2022
- Advanced glycation end products and their receptors in serum of patients with type 2 diabetesScientific Reports, 2021
- Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to CorrectionBulletin of Experimental Biology and Medicine, 2021
- Effects of 22 traditional anti-diabetic medicinal plants on DPP-IV enzyme activity and glucose homeostasis in high-fat fed obese diabetic ratsBioscience Reports, 2021
- Development of stable emulsified formulations of Terminalia arjuna for topical application: evaluation of antioxidant activity of final product and molecular docking studyDrug Development and Industrial Pharmacy, 2019
- Anti-hyperglycemic and anti-hyperlipidaemic effect of Arjunarishta in high-fat fed animalsJournal of Ayurveda and Integrative Medicine, 2017
- Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A reviewJournal of Traditional and Complementary Medicine, 2017
- Attenuation of glycation-induced multiple protein modifications by Indian antidiabetic plant extractsPharmaceutical Biology, 2016
- Recent development of plant products with anti-glycation activity: a reviewRSC Advances, 2015
- Antioxidant and antimutagenic activities of bark extract of Terminalia arjunaAsian Pacific Journal of Tropical Medicine, 2010